Form 4: Zai Lab Officer Joshua L. Smiley Reports Stock Option and Restricted Share Unit Grants

Joshua L. Smiley, President and COO of Zai Lab, reports the acquisition of stock options and restricted share units.

Summary

• On April 1, 2024, Joshua L. Smiley, President and Chief Operating Officer of Zai Lab Ltd, reported the acquisition of stock options and restricted share units.
• Smiley acquired 197,306 stock options with an exercise price of $16.72.
• These options vest in equal annual installments over four years, starting April 1, 2025.
• Smiley also acquired 128,249 restricted share units (RSUs).
• These RSUs also vest in equal annual installments over four years, beginning April 1, 2025.
• Each stock option and RSU represents the right to acquire one American Depositary Share (ADS), which in turn represents ten Ordinary Shares of Zai Lab.
• Following the reported transactions, Smiley directly owns 197,306 stock options and 128,249 RSUs.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, indicating a stable and incentivized management team. This is generally viewed positively.

Positives

• The grant of stock options and RSUs aligns the executive's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the executive.

Industry Context

The granting of stock options and restricted share units is a common practice in the pharmaceutical industry to incentivize executives and align their interests with those of shareholders. This aligns with standard compensation practices for publicly traded companies.

Comparison to Industry Standards

• Stock option and RSU grants are a common component of executive compensation packages in the biotech and pharmaceutical industries.
• Companies like Amgen, Gilead Sciences, and Biogen also utilize similar equity-based compensation to incentivize their executives.
• The vesting schedules, typically over a four-year period, are also standard practice in the industry to promote long-term commitment.

Stakeholder Impact

• Shareholders may view the equity grants positively as they align management's interests with the company's long-term success.
• Employees may be motivated by the potential for future equity grants and the company's commitment to incentivizing its leadership.

Key Dates